Showing results (351-360 of 433) with videos related to

Sort By:
Pageof 44
The Lancet. Neurology|August 2, 2008
Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trialLars Lannfelt, Kaj Blennow, Henrik Zetterberg, et al.
Aging & Mental Health|June 5, 2026
Midlife dementia risk and later dementia-related fear and avoidance: evidence from a prospective cohort studyFrancesca R Farina, Katie Bridgeman, Georgios Ntailianis, et al.
Journal of Alzheimer'S Disease : JAD|May 18, 2020
Hippocampal Subfield Volumes in Middle-Aged Adults at Risk of DementiaAnna McKeever, Alvar F Paris, James Cullen, et al.
Animals : an Open Access Journal From MDPI|October 29, 2020
Molecular Assessment of Chelonid Alphaherpesvirus 5 Infection in Tumor-Free Green (Chelonia mydas) and Loggerhead (Caretta caretta) Sea Turtles in North Carolina, USA, 2015-2019Annie Page-Karjian, Maria E Serrano, Jeffrey Cartzendafner, et al.
Alzheimer'S Research & Therapy|November 13, 2024
Associations between sex and lifestyle activities with cognitive reserve in mid-life adults with genetic risk for Alzheimer's diseaseQing Qi, Feng Deng, Rebecca Sammon, et al.
Mobile DNA|May 11, 2019
Characterization of a relaxase belonging to the MOBT family, a widespread family in Firmicutes mediating the transfer of ICEsNicolas Soler, Emilie Robert, Isaure Chauvot de Beauchêne, et al.
Plos One|March 19, 2019
Evidence of bromethalin toxicosis in feral San Francisco "Telegraph Hill" conuresFern Van Sant, Sayed M Hassan, Drury Reavill, et al.
Frontiers in Dementia|July 31, 2024
Remote data collection speech analysis in people at risk for Alzheimer's disease dementia: usability and acceptability resultsSarah Gregory, John Harrison, Janna Herrmann, et al.
Journal of the American Veterinary Medical Association|April 3, 1998
Use of an inactivated virus vaccine to control polyomavirus outbreaks in nine flocks of psittacine birdsB W Ritchie, S B Vaughn, J S Leger, et al.
International Journal of Geriatric Psychiatry|January 18, 2006
A comparison of the efficacy and safety of olanzapine and risperidone in the treatment of elderly patients with schizophrenia: an open study of six months durationC W Ritchie, E Chiu, S Harrigan, et al.
Pageof 44